-
2023-507560-39-00
Acquired Antithrombin Deficiency (Heparin Resistance) 5 2025-01-07
-
2024-511789-35-00
Myocardial ischemia
Myocardial infarction 6 2025-01-05
-
2024-519969-21-00
Infective endocarditis 6 2025-01-01
-
2022-501547-33-01
Acute myocarditis 11 2024-12-24
-
2023-505048-20-00
Arrhythmogenic right ventricular dysplasia 4 2024-12-20
-
2023-509717-36-00
AF patients who have undergone successful PCI 5 2024-12-16
-
2023-503602-37-00
Cardiogenic Shock 5 2024-12-16
-
2024-515987-29-00
Out-of-hospital cardiac arrest 11 2024-12-11
-
2024-518338-10-00
heart disease 6 2024-12-10
-
2023-507489-20-00
Statin-intolerance 6 2024-12-10
-
2024-516967-10-00
Hyperlipidemia 6 2024-12-10
-
2024-513092-40-00
Stroke 6 2024-12-05
-
2023-506299-28-00
Postoperative pain after cardiac surgery 6 2024-12-02
-
2023-508148-23-01
chronically occluded coronary artery 5 2024-12-02
-
2024-517408-12-00
Patient in end-stage renal disease candidate for a kidn 5 2024-11-28
-
2024-514489-38-01
giant cell arteritis 4 2024-11-26
-
2023-508208-40-00
All adult patients with successful transfemoral trans-a 10 2024-11-21
-
2023-507981-17-00
CMD 4 2024-11-20
-
2024-515893-29-01
Coronary artery disease 10 2024-11-19
-
2024-518890-33-00
Chronic coronary syndrome 6 2024-11-12
-
2024-514491-40-00
giant cell arteritis 4 2024-11-12
-
2024-515705-26-00
Stroke 4 2024-11-11
-
2023-508475-36-00
Atherosclerotic Cardiovascular Disease 5 2024-10-29
-
2023-504504-28-00
Patients with atrial fibrillation requiring anticoagula 5 2024-10-25